Overall, these findings suggest that lower QKI and MacroH2A1.1 expression levels might be associated with worse PCa-related survival, a hypothesis that follows the same reported for other cancer models, but which requires further investigation in a larger cohort of PCa patients. This evidence concerns the gene QKI and cancer.